Time trends of primary antibiotic resistance of Helicobacter pylori isolates in Southern Croatia

Journal of Chemotherapy

Volumn 24, Issue 3, 2012, Pages 182-184

  Tonkic, Ante ^a,b   Tonkic, Marija ^a,b   Brnic, Darko ^a,b   Novak, Anita ^a,b   Puljiz, Zeljko ^a,b   Simunic, Miroslav ^a,b  

^a UNIVERSITY HOSPITAL SPLIT   (Croatia)

^b UNIVERSITY OF SPLIT   (Croatia)

Author keywords

[No Author keywords available]

Indexed keywords

AMOXICILLIN; CLARITHROMYCIN; LEVOFLOXACIN; METRONIDAZOLE; TETRACYCLINE;

ANTIBIOTIC RESISTANCE; ARTICLE; BACTERIAL STRAIN; BACTERIUM ISOLATE; CROATIA; DYSPEPSIA; EPSILOMETER TEST; GRAM STAINING; HELICOBACTER PYLORI; HUMAN; MAJOR CLINICAL STUDY; NONHUMAN; STOMACH MUCOSA; STOMACH ULCER; TREND STUDY;

ADULT; ANTI-BACTERIAL AGENTS; CLARITHROMYCIN; CROATIA; DRUG RESISTANCE, BACTERIAL; HELICOBACTER INFECTIONS; HELICOBACTER PYLORI; HUMANS; TIME FACTORS;

EID: 84866247249     PISSN: 1120009X     EISSN: 19739478     Source Type: Journal    
DOI: 10.1179/1973947812Y.0000000001     Document Type: Article

References (15)

1. Malfertheiner P, Megraud E, O'Morain C, Bazzoli F, El-Omar E, Graham D, et al. Current concepts in the management of Helicobacter pylori infection. The Maastricht III Consensus Report. Gut. 2007;56:772-81.
2. Megraud F. Helicobacter pylori antibiotic resistance: prevalence, importance, and advances in testing. Gut. 2004;53:1374-84.
3. Vakil N, Megraud F. Eradication therapy for Helicobacter pylori. Gastroenterol. 2007;133:985-1001.
4. Vakil N. Helicobacter pylori treatment: new wine in old bottles?. Am J Gastroenterol. 2009;104:26-30.
5. Graham DY, Shiotani A. New concepts of resistance in the treatment of Helicobacter pylori infections. Nat Clin Pract Gastroenterol Hepatol. 2008;5:321-31.
6. Fischbach L, Evans EL. Meta-analysis: the effect of antibiotic resistance status on the efficacy of triple and quadruple first-line therapies for Helicobacter pylori. Aliment Pharmacol Ther. 2007;26:343-57.
7. de Francesco V, Giorgo F, Hassan C, Manes G, Vanella L, Panella C, et al. Worldwide H. pylori antibiotic resistance: a systematic review. J Gastrointestin Liver Dis. 2010;19:409-14.
8. Rimabara E, Fischbach LA, Graham DY. Optimal therapy for Helicobacter pylori infections. Nat Rev Gastroenterol Hepatol. 2011;8:79-88.
9. O'Connor A, Gisbert JP, McNamara D, O'Morain C. Treatment of Helicobacter pylori infection 2011. Helicobacter. 2011;16:53-8.
10. Glocker E, Stueger HP, Kist M. Quinolone resistance in Helicobacter pylori isolates in Germany. Antimicrob Agents Chemother. 2007;51:346-9.
11. Tonkic A, Tonkic M, Goic-Barisic I, Jukic I, Mise S. Antibiotic resistance of Helicobacter pylori isolated in Split, Southern Croatia. Int J Antimicrob Agents. 2005;25:449-50.
12. Tonkic M, Tonkic A, Goic-Barisic I, Jukic I, Simunic M, Punda-Polic V. Primary resistance and antibiotic minimum inhibitory concentrations for Helicobacter pylori strains in Split, Croatia. J Chemother. 2006;18:437-9.
13. Tonkic A, Tonkic M, Brnic D. Increasing prevalence of primary clarithromycin resistance in Helicobacter pylori strains in Split, Croatia. J Chemother. 2009;21:598-9.
14. Romano M, Marmo R, Cuomo A, de Simone T, Mucherino C, Iovene MR, et al. Pretreatment antimocrobial susceptibility testing is cost saving in the eradication of Helicobacter pylori. Clin Gastroenterol Hepatol. 2003;1:273-8.
15. Graham DY, Fiscbach L. Helicobacter pylori treatment in the era of increasing antibiotic resistance. Gut. 2010;59:1143-53.